Skip to main content

Persistent Asset Partners Ltd

Position in ABVX — Abivax S.A.

CIK 2056052 HONG KONG, K3

Position in ABVX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$5,897,553
+$3,354,542 QoQ
Shares Held
44,256
+93.8% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
1.96%
of 13F equity value
Holder Rank
#107
of 301 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ABVX Over Time

Shares Held

Position Value (USD)

Derivatives in ABVX

reported options exposure · as of Jun 30, 2026
CallValue
$118,598
CallShares
890
PutValue
$17,196
PutShares
644

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. ABVX ranks #2 (7.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABVX
Abivax S.A.
This page
44,256 $5,897,553

All Filings in ABVX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $118,598 890
2026-06-30 $5,897,553 44,256
2026-06-30 $17,196 644
2026-03-31 $28,171 253
2026-03-31 $28,171 253
2026-03-31 $2,543,011 22,838
2025-12-31 $3,292,214 24,413
2025-09-30 $815,379 9,604